(S)-HOMOQUISQUALATE - A POTENT AGONIST AT THE GLUTAMATE METABOTROPIC RECEPTOR

被引:31
|
作者
PORTER, RHP
ROBERTS, PJ
JANE, DE
WATKINS, JC
机构
[1] UNIV SOUTHAMPTON,DEPT PHYSIOL & PHARMACOL,BIOMED SCI BLDG,SOUTHAMPTON SO9 3TU,HANTS,ENGLAND
[2] UNIV BRISTOL,SCH MED SCI,DEPT PHARMACOL,BRISTOL BS8 1TD,AVON,ENGLAND
关键词
HOMOQUISQUALATE; QUISQUALATE; (1S; 3R)-ACPD; GLUTAMATE METABOTROPIC RECEPTOR;
D O I
10.1111/j.1476-5381.1992.tb14366.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The synthetic quisqualate analogue, (S)-homoquisqualate was examined for activity at the glutamate metabotropic receptor, in relation to its ability to stimulate phosphoinositide hydrolysis in rat pup cerebro-cortical slices. The compound produced a robust increase in hydrolysis (EC50 = 50.2+/-1.6-mu-M), which, in common with responses to quisqualate and (1S,3R)-1-aminocyclopentane-1,3-dicarboxylate ((1S,3R)-ACPD), was antagonized uncompetitively by L-2-amino-3-phosphonopropionate (L-AP3). In contrast to quisqualate which exhibits low efficacy, (S)-homoquisqualate behaves as a full agonist at the metabotropic receptor.
引用
收藏
页码:509 / 510
页数:2
相关论文
共 50 条
  • [21] Group I metabotropic glutamate receptor agonist causes neurodegeneration in rat hippocampus
    Ong, WY
    Balcar, VJ
    JOURNAL OF BRAIN RESEARCH-JOURNAL FUR HIRNFORSCHUNG, 1997, 38 (03): : 317 - 322
  • [22] A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activity
    Stanley, Nathan J.
    Hutchinson, Mark R.
    Kvist, Trine
    Nielsen, Birgitte
    Mathiesen, Jesper Mosolff
    Brauner-Osborne, Hans
    Avery, Thomas D.
    Tiekink, Edward R. T.
    Pedersen, Daniel Sejer
    Irvine, Rodney J.
    Abell, Andrew D.
    Taylor, Dennis K.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (16) : 6089 - 6098
  • [23] Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
    Moghaddam, B
    Adams, BW
    SCIENCE, 1998, 281 (5381) : 1349 - 1352
  • [24] ACTIONS OF A METABOTROPIC GLUTAMATE RECEPTOR AGONIST IN IMMATURE AND ADULT-RAT CEREBELLUM
    EAST, SJ
    GARTHWAITE, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 219 (03) : 395 - 400
  • [25] A METABOTROPIC GLUTAMATE RECEPTOR AGONIST DOES NOT MEDIATE NEURONAL DEGENERATION IN CORTICAL CULTURE
    KOH, JY
    PALMER, E
    LIN, A
    COTMAN, CW
    BRAIN RESEARCH, 1991, 561 (02) : 338 - 343
  • [26] A novel series of potent and selective noncompetitive antagonists of metabotropic glutamate receptor 1
    Li, L
    Tomlinson, R
    Wang, Y
    Tsui, HCT
    Chamberlain, MJ
    Johnson, MP
    Baez, M
    Vannieuwenhze, MS
    Zia-Ebrahimi, M
    Hong, EJ
    Schkeryantz, JM
    Monn, JA
    Porter, WJ
    Baker, SR
    Owton, WM
    Clark, BP
    Kingston, AE
    NEUROPHARMACOLOGY, 2002, 43 (02) : 295 - 295
  • [27] Role of the metabotropic glutamate receptor on Huntington's disease
    Ribeiro, F. M.
    Anborgh, P. H.
    Cregan, T.
    Ferguson, S. S.
    JOURNAL OF NEUROCHEMISTRY, 2007, 102 : 198 - 198
  • [28] Receptor subtypes linked to metabotropic glutamate receptor agonist-mediated limbic seizures in mice
    Tizzano, JP
    Griffey, KI
    Schoepp, DD
    NEUROPROTECTIVE AGENTS: CLINICAL AND EXPERIMENTAL ASPECTS, 1995, 765 : 230 - 235
  • [29] LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia
    Bond, A
    Ragumoorthy, N
    Monn, JA
    Hicks, CA
    Ward, MA
    Lodge, D
    O'Neill, MJ
    NEUROSCIENCE LETTERS, 1999, 273 (03) : 191 - 194
  • [30] Metabotropic glutamate receptor antagonist
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (06) : 262 - 262